Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Gearing Up for Phase 3 Trial of Tecarfarin Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a ...

Learn about atrial septal defects in babies, including symptoms, diagnosis, treatment options, and long-term outlook for this ...

In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

As heart failure patients, the TAVI population studied already is recommended to be treated with an SGLT2 inhibitor, noted ...

Changes in the heart might mean more than just cardiovascular risk – they could also signal early shifts in brain health. A ...

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life ...

The treatment was carried out in September 2024 at the National Heart Centre Singapore (NHCS), which treats cases of ...

After six days in the hospital, Punturi was sent home with medicine, but on Sept. 8 as he was watching the Steelers beat the ...